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~903-11] AngiopiasWinAcuteMYOCardiallnfarctiOnin
ClinicaiPractice:Reeuitsin4625PatiantsFromtha
ALKKAngioplastyRegietry
R. Zahn, A. Vogt, K.-L. Neuhaus, S. Schuster, J. Senges for the ALKK
Study Group. Herzzerttrum Ludwigsfrafen, Germany
Angioplasly (A-AMI) has shown to be an effective therapy in patients (pt.)
with acute myocardial infarction (AMI). However, numbers of pt. treated
with A-AMI are still small and little is known about the use of A-AMI outside
highly specialized centers. We therefore analyzed thedataof the angioplaafy
ragistryof the ALKK, a group of non university hoepitalsin Germany.Behyeen
10/92 and 1295 a total of 81724 angioplastias were registered, including
4625 (5.7%) A-AMI. There were 75.1% men and the mean age was 61 +11
yeara (21-89 Y).Total occlusions of the infarct related artery were present in
3259 (70.5%)andastenosis 290% in874 (18.9%)pt. Tachnicalaucceasrate,
defined as stenosis after A-AMl < 50% WSS86%,and 5% showed a reaidual
stenosis of 250% and 40$’.. Additional thrombolysia wee given in 417 (9%)
pt. and stents were implanted in 443 (9.6%) pt. Bypass aurgery following PA
wee performed in 139 (3%) pt. Total hospital mortality was 9.6% (438 pt.).
There was a higher monallty in hospitals patforming s 40 A-AMI/year aa
compared to those with =-40 A-AMI/year (11.4% versus 8.1%, OR = 1.59,
95°ACl = 1.3&l .95). CorWrs/on: Inclinical pracfice A-AMl can bepetformad
with a high promcfurei success rate. Mortality in this multi-center registrywas
similar to that reported by large single oenter registries.
D90312 DiscrepancyBetweenActualvs.PotentialTreatmentinAcuteMyocardiainfsrotion:Useof
Thrombolytics,Aspirin,Bets-blockersand
ACE-inhibitorsinGermany1996.MITRAStudy
S.Schuster, U. Burczyk, R. Schiele, R. Zahn, A. Koch, H.G. Glunz,
U. Gieseler, J. Senges for the MITRA-StudyGrouP. Herzzentnrrn
Ludwigshafen, Germany
Tha aim of this study is to document actual clinical practice (pilot-phase)
and to improve the therapy of acute Ml individually according to published
recommendations. In the study phase, we used an educational program for
pstticipants. They were advised to consider only major contraindications for
each prognostically important drug.
MITRA isagerman registry of 54 hoepitals in tha Southwest. The total pts.
group consisted of 4178 patients with proven q-wave myooardial infarction.
Patients were documented consecutively and were enrolled even up to 96
hours after onset of aymptoms. Median age was 66 yeara, prehospitel delay
2.7 h, anterior Ml 48%, previous infarction 17.47..
Pilot-phase(n= 1303) Study phase (n= 2S75)
Pts. without Pm actualtreated Pta without Pts.actualtreated
contraindic. “ (%) ccmtraindic. “
(%) (%)
(%)
Thrombolysis 56.6 602 53.4 79.1 1373 60.4
Aspirin 99.7 1138 87.6 99.3 2724 95.4
p-Blocker 84.0 408 37.1 S2.6 1543 65.0
ACE-inhibit. 86.7 197 17.4 34.6 1559 64.1
Primary PTCA increased from 8.3% (pilot) to 11.4%(study phase).
Conclusion: Pharmacological therapy in acute Ml is inconsistent with the
recommendations of racent clinical trials as documented in the pilot phaae.
An individually optimized therapeutic concept, which considers only major
contraindications for each drug improves infarction therapy particularly for
beta-blocker and ACE-inhibitor.
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D90425 UnprouxtedLeftMainStanting:PreliminaryResuitaandFollow-upwiththe Firat41 Patients
M. Silvestri, P.Barragan, J.B. Sim60ni, P.O.Roquabert, G. Bayat,
J. Sainsous. Centre Carr.lio-VasculaireLas Alpilles, Marseille, France
Unprotected left main coronary artery (LMCA) angioplasty has been associ-
ated with a high procedural complication rate and short-term mortality. The
availability of etente and their success in reducing acute complications and
restenoeis may cause to re-examine the role of PTCA for LMCA disease.
Unprotected LMCA stent implantation was petformed electively in 41 con-
secutive patients (pts) included 20 poor candidate (group 1) and 21 god
candidates for CABG (group 2). Clinical data were in group 1: 15 males,
mean aga of 70 + 7 years, 10 pts with unstable angina (UA), mean LVEF
of 47 + 15%, 13 pts with prior cardiac surge~ and in group 2: 17 males,
mean age of 63 * 11 years, 11 pts with UA, mean LVEF of 64 + 11%. All
pts were treated with Ticlopidine (2 x 250 mg daily) etarted 3 days before
PTCA. Indications for atenting were elective for 39 pts and dissection for 2
pts. Angiographlc success was achieved in all pte with 54 stents (38 Paimez-
Schatz, 7 Gianturm-Roubin, 5 Saint-Come, 3 AVE and 1 Multi-Link stertta).
PTCA of 42 other vessels (inciuding 9 right cmonary artery) were alao dona
with 7 other stent implantations. Two subacute thrombosis occurred during
hospital stay in group 1, involving 2 deaths (4.7%). Nocardiacevent occurred
in group 2. Clinical follow-up was available in all pts (mean Interval of 13 +
IO months) ss foliow: 1 death in group 1, repeat LMCA PTCA for angina,
recurrence in 3 pts (177.) of group 1 and in 1 pt (5%) of group 2. Conokrsiom
Unprotected LMCA stenting with a 17clopidine regimen can be considered
as a safe and effective percutaneous intervention in selected pts. Neverths-
iess randomized trtais LMCA stenting versus surgety are necessary in good
candidates for CABG.
- StentingofWnprotscted-LeflMalnCoronary
ArteryStenosas:EariyandLateReaulta
C.J.J. Leruelle, G.B.R. Brueren, E.T.Ss1,S.M.P.G. Ernst, G.E. Maat,
M.-J. Suttorp, A.B. de la Riviere, H.W.T.Plokker. Depts of Cwdio/ogy&md
Cardiothoracic Surgery StAntonius Hospital, Nieuwegein, NL
Efackgrourrd:Transluminai angioplasfy of “unprotected” left main ooronary
artery (LMCA) stenosis is still considered to be contraindicated even in the
age of stenting.
Objectives: We reviewed the results of coronary stent (S) implantation in
“unprotected” LMCA stenosis in 18 consecutive patients (10 eleclive proce-
dures, 8 acute procedures)to asses shofl and iong-term effectiveness of this
procedure.
Popu/atiorr: Mean age was 70.8 yearn (range 36 to 91). Twelve men.
Fourteen pts had normal left ventricular function. Sevan patients had only a
significant lesion in the LMCA.
Results: Successful S-implantation was achieved in all patients with a
maximum balloon inflation preasure of at least 16 atmoapheree and a mean
maximum balloon size of 4.3 mm. Six pta underwent additional angiopiasty
of other atenoaea during the procedure. No major cardiac evente (acute
myocardial infarction, cardiac death, corona~ artery bypass aurgary, repeat
angiopiaety) occurred during tha procedure in the eiective group. In the
emergency group, one pt died, one pt underwent emergency coronary artety
bypaaeaurgery,one ptdeveloped a non q wave myocerdial infarction. During
hospital stay, one pt underwent a rapeat angioplasty in the elective group,
and one pt in the emergency group died suddeniy. Follow-up wee obtained
in all suwiving pts, at a mean interval of 9 monthe, there were 2 non related
death; one pt had clasa 2 angina and 12 pte had no eymptoms.
Conclusion: We mnclude that stent implantation in “unprotected” LMCA
stenosis using high pressure for S-delivaw can be conaiderad a safe and
effective coronary revaeculanzation option in selected patients in eiective
conditions. The short-term prognosis in emergency situations remains poor.
e] stentimP,an~tion Afiersucceesfui~a,,oo.
Angiopiaetyof a ChronicCoronaryOcclusion- A
RandomizedTriai
H. Sieverf’, S. Rohdel, R. Schulze2, A. Utech3, R. Eneelen1, H. Spies’,
D. Schererl, R. Schr~der, H. Merle, A. Fach 1.1 Cardiovascular Center
Bethanian CCB, Frankfurt, Gerrnan~ 2Klinik Dr Haerec U/m, Gerrnan~
3Rot-Kreuz Krankenhaus, Kassal, Germany
The restenosis rate after angioplasty for chronic totai coronary occlusion is
much higher compared to coronary stenoses. The benefit of etent implanta-
tion in this situation ia unknown.
60 Patiente were randomized after successful ballocm angioplasty of a
chroniccoronaryocclusionto’’stent” implantation orto ”nostent.” The bsaeline
characteristics of both groups showed no difference. Follow-up angiogram
was performed after4 monthaor earlier if necesaa~ for clinical reaaona.
Nostent Stent D
MLD (mm) 1.75 2.69 <0.001
‘/oStenosis 21.6 5.s <0.001
Reocdusion(%) 12 0 n,s.
Reetenoais>50”A 64 28 < 0.05
Re-PTCA orCABG (%) 52 24 < 0.05
ML04 months(mm) 0.95 1.s5 <0.01
O/.Stenosia4 months 61 33 <0.01
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The results of the of the first 50 patients are available and shown in the
table.
Corfc/usiorJ:Stentimplantation after successful recenalizationand belloon
dilatation of a chronic coronary occlusion improved acute and long-term
angiographic and clinical outcome.
D90428 Six-Month Angiographic Follow-Up After Stenting
of Chronic Totsl Coronery Occlusions
S. Elezi, H. Schilhlen, J. Hausleiter, J. Pache, N. Mszilli, E. Aft,
J. Dirschinger, A. Sch5mig. Deutsches Herzzentrum Murrchen, German~ 1.
Medizhr/scheKlhrik, Tmhnische Universitat, Munich, Germany
We compared the angiographic outcome of 54 patients (55 lesions) with
chronic total coronary occlusions (OCC) versus 972 (1303 lesions) with non-
ooolusive stenoses (STEN), all with successful stent placement. OCC waa
defined es abaenoe of antegrade flow with more than 1 month of asaumed
duration. Restenosia was defined as a percent diameter stenosis >50%.
Quantitative angiographic analysis was performed on per-lesion basis by
kdge detection algorithm. OCC pts were younger than STEN pte (58 yrs.
vs. 61.6 yrs. p = 0.01), but did not differ with respect to sex and vessel
distribution. Angiographic follow-up was performed in 77.8Y0 of OCC lesions
and in 70.8% of STEN lesions (p = ns).
Occ STEN p-value
Reference dianwter (mm) 3.18+ 0.58 3.o2 + 0.53 ns
Acute gain (mm) 2.96+ 0,51 2.20 * 0.64 <0.0001
Number of atentsJleaion 3,2 + 2.1 2.4 + 1.5 <0.0001
Elasticrecoil(mm) 0.29+ 0.23 0,29 + 0.22
Late loss(mm) 1.3s+0.9 1.13 * 0.79 :s042
Loseindex 0.47+0.29 0,52 + 0.41
%-diameter stenosia 46.5*29.3 38,5 & 23.6 :s033
Restenoaisrate (%) 39.5 25,9 0.049
Reccclusionrate (%) 14.0 2.5 <0.0001
Conclusions: Patients with chronic total occlusions have a higher rate of
restenoais and reocclusion despite favoureble acute results.
1 CoronevStent~,~c~~enti
Six-Month Clinical and Angiographic Follow-Up
H. SchUhlen,J. Hausleiter, S. Elezi, H. Walter, A. Wehinger, N. Mezzilli,
J. Direchinger, A. Schdmig. Deutsches Herzzentrum Mihrchen, Gemrarr~ 1.
M&izinbche Klinik, TechnischeLfniversitat,Munich, Germany
PTCA of oetial Ieeiona is technically difficult and has a higher complication
rate during follow-up. To study the impact of atenting on the subsequent
follow-up, we retrospectively analyzed clinical and angiographic data of 184
patients with stents in aorto-ostial (left main, RCA, bypass grafts; n = 70) or
brsnchpoint-ostial Ieaions(LAD, LCX,n = 94), in comparison to 1600 patienta
with non-ostial atents. There was no significant difference in rates of major
cardiac events during the first 4 weeka (5.5 VS3.6%; p = ns). At 6 months,
patients with ostial lesions needed more repeat interventions (15.8 vs. 8.4%;
p = 0.02).
Ostial Non-ostial p-value
MLD before PTCA (mm) 0.83+0.87 0.73 + 0.48 na
Ref D before PTCA’(mrn) 3.16+ 0,62 3.09 +0.57 ns
MLD after stenting(mm) 3.10+ 0.60 2.96+ 0.50 <0.01
Ref D atterstenting (mm) 3.33 * 0.59 3,17 * 0,51 <0.01
balka to vessel ratio 1.13 +0.20 1,07 l 0.19 0.01
MLD at follow-up(mm) 1.92 * 0.85 1,96 + 0,S7 ns
RefDatfollow-up(mm) 3.12+0.59 3.06+ 0.54 na
Latelumen10ss[mm) 1.18+ 0.81 10I + 0.83 <0.03
Reatenosiarate ~%) 33,3 25,7 ns
Conclusions: Stents in ostialIesionado not resultin higher rates of sub-
sequent death, Ml or stent vessel occlusion. However, repeat Interventions
are more frequent after 8iX months, due to a aignificently higher late lumen
loss and a trend for higher restenosie rate.
a90430 “LAD-LCX Angle” as a Predictor of LCX Narrowingby Stenting or DCA for LAD Ostial Lesions (OL)
S. Takegi, Y. Aaakura, S. Ishikewa, H. Kanki, M. Nakagawa, M. Sakamoto,
S. Ogawa, T. Hinohara. Keio University Tokyo,Japan
To evaluate the utility of new technologies for OL treatment, we studied the
initial and follow-up outcomes in 24 casea treated at LAD OL with Palmez-
Schatz atent (PS) or directional coronary atherectomy (DCA). PS was im-
planted in 11and DCAwas performed in 13cases. Percentdiameter stenosis
at the target lesions and LCX ostial diameter were measured before (pre)
and after (post) procedures with quantitative coronary angiography. LCX ratio
was defined as posr/pre LCX diameter. The angle of LAD and LCX observed
at the view of RAO 30Qand Caudal 309, named as “LAD-LCX angle”, was
measured, respectively. In all cases, target lesion revascularization during
6 months was assessed. Between 2 groups, no significant differences were
obaerved in angiographical characteristics. Initial .succesa rate was 100% in
both groups. No major complication (AMI, CABG, death) was not occurred.
LAD diameter stenosis LCX oatialdiameter (mm)
pre post pre peat
Ps 81.3 + 3.4 –8.1 + 5.7 2.9 + 0.2 2.6 + 0.28
DCA 62.S + 2.6 –2,7 + 3.9 2.9 + 0.2 2.9 + 0.3
*p <0.01 vs. pre
When LAD-LCX angle wass 802,LCX ostium was significantly narrowed
by stenting (LCX ratio = 0.89 + 0.03 [S 8@, n = 71,0.97 & 0.01 [>8rY, n
= 4], p < 0.01). Narrowing of LCX ostium with stenting did not improve at
repeated angiogrsphy, and angioplasty for LCX ostium was needed in one
patient. Target lesion revascularization was in 2 of P-S stent (18%), and in
2 of DCA (15%) (N.S.). This finding demonstrated that treatment of LAD OL
can be accomplished safely and effectively with both PS and DCA when
IAD-LCX angle >60Q.However, in cases with LAD-LCX angle s 60Q,DCA
is a favorable therapy rather than P-S stent to avoid the narrowing of LCX
ostium.
-] ‘IT’’Shapedstent p,acement:atechni~ueforthe
treatment of coronary bifurcation lesions
D. Carri6, M. Elbez, M. Mebarkia, F.S.Cricq, M. Delay, P.Berdague, J. Puel.
Department of Cardiology, Purpan Hospital, Toulouse, France
Corona~ bifurcation lesions are considered as complex because of the high
risk inherent in conventional angioplasty.
As experience with treating side branches within a stented segment has
grown, there has been increased interest in developing a practical approach
forstenting both the main vessel and a large side branch, oratrue bifurcation
lesion. Various techniques to predictably treat both the main vessel and the
branch involved have thus been explored. We report our prelimina~ reauits
of “T” stenting (Wiktor Stent – Medtronic), with placement of a stent in the
ostium of the side branch involved, followed by placement of a second stent
in the main vessel spanning the origin of the side branch. This new technique
was used on 21 patents (pts) with bifurcation lesions (14 de novo lesions, 3
restenosis, 4 bail-out situations). In 17/21 cases, the “T” stent was implanted
at the bifurcation of the left anterior descending artery (MD) and its firat or
second diagonal branch (D), in 2 cases at the LAD-circumflex bifurcation, in
one ease at the bifurcation LAD-D of saphenous vein graft and in one case
at the circumflex-marginal bifurcation. In one caae, due to an access-failure
in D, one stent was implanted in the LAD only without complications.
Angiogtaphic and procedural data were:
Main branch Side branch
Artew diameter (mm) 3.1 + 0.6 2.7+ 0.9
Leai& length(rnm) 15*6 9.3*4
Pre-PTCA MLD (mm) 0.7 & 0.4 0.6 * 0.7
Stent length(mm) 16 16
Stentdiameter (mm) 3.2 + 0.3 3 + 0.3
FinalMLD (mm) 2.9+ 0.7 2.3 + 0.9
Residualatenosis‘A 18+ 12 14* 10
Initialsuccess 21/21 20/21
Angiographicrestenoais(F.U.) 2/21 3/20
At six month follow-up, all the patients were cardiac event free and the
angiographic control showed restenosis in the main vessel in 2 cases and
three restenosesinthesidebranch, requiring PTCAintwocasesand medical
treatment in the three others.
Cone/usion:The”T’’stent technique can be performed safely with aWiktor
Stent in coronsry bifurcation lesions and remains a mainatay for this lesion
morphology until pre-formed bifurcation stents are developed.
1 C0r0naryStentin90f Sma,l Coronary Arteries.
Preliminary Reaults of a Pilot Study with the 2.5
mm Microstent AVE
M.C, Morice, B. Valeix, R. Bradai, P. Dumas, Y. Louvard, T. Lefbvre,
P. Labrunie. /CVParis Sud, UCVMarsei//e, France
Coronary atenting demonstrates its capacity to increase acute success of
PTCA and to prevent restenosia in arteries of 2.7 mm and more. However
stenting of small atteries is associated with a high risk of subacute thrombosis
